[PLX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 0.81%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 47,638 38,350 62,898 54,693 34,240 19,242 9,199 31.51%
PBT -14,397 -27,582 -6,523 -18,276 -26,457 -85,276 -29,176 -11.10%
Tax 530 6,403 8,369 7,966 536 7,805 10,854 -39.52%
NP -14,927 -33,985 -14,892 -26,242 -26,457 -85,276 -29,365 -10.65%
Tax Rate - - - - - - - -
Total Cost 62,565 72,335 77,790 80,935 60,697 104,518 38,564 8.39%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -31.33 -88.62 -23.68 -47.98 -77.27 -443.18 -319.22 -32.07%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.31 -0.77 -0.51 -1.77 -1.80 -6.51 -0.29 1.11%
EPS Diluted -0.31 -0.77 -0.51 -1.77 -1.80 -6.51 -0.29 1.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.